The staff of the Neuropathology Core has a central role in our Alzheimer's Disease Research Center (ADRC). They perform neuropathological/neurobiological evaluations of the brains of human subjects, help with the assessments of transgenic animal models, train physicians/scientists in issues relevant to neurodegenerative diseases, and collaborative with the medical and research communities in diagnostic/research activities relevant to aging and alzheimer's disease (AD). Investigators supported by this Core have a longstanding history of productive collaborations in basic and clinical research on age- associated neurodegenerative disorders. This Core has several specific goals: to arrange/conduct autopsies and establish diagnoses in controls and demented subjects, including individuals from the Baltimore Longitudinal Study of Aging (BLSA); measure pathological-morphometric- neurochemical variables in brain tissue; to facilitate analyses of transgenic mouse models of neurodegenerative disorders; to validate a system for grading the pathological severity in cases of AD; and to obtain, store and distribute human brain tissues for intramural and extramural basic research. To accomplish these goals, the staff maintains the Brain Resource Center (BRC), a histology/immunocytochemistry laboratory, a quantitative morphometry/stereology laboratory, and facilities for neurochemical/receptor autoradiographic analyses. The BRC serves as a repository of fixed and frozen tissues prepared for research from >780 subjects, including controls, cases of AD, and cases with other types of dementia. The functions of this Core have been enhanced by several new developments. The autopsy program has been expanded to include greater numbers of control subjects, minority subjects, and cases of Parkinson's disease with and without dementia. Serum and cerebrospinal fluid samples are stored for future studies. A stereology unit has been established for the unbiased quantitation of neurons/synapses. Finally, because of the importance of genetic factors in neurodegenerative disorders, the faculty of this Core assists in the analyses of transgenic mice, thus taking advantage of our expertise in investigations of animal models of neurodegenerative disease. Through these manifold activities. This Core acts to support and coordinate the evaluation of clinical and experimental material, thereby facilitating key diagnostic and research capacities of our ADRC.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
5P50AG005146-14
Application #
5204514
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
1996
Total Cost
Indirect Cost
Seddighi, Sahba; Varma, Vijay R; An, Yang et al. (2018) SPARCL1 Accelerates Symptom Onset in Alzheimer's Disease and Influences Brain Structure and Function During Aging. J Alzheimers Dis 61:401-414
Fredericks, Carolyn A; Sturm, Virginia E; Brown, Jesse A et al. (2018) Early affective changes and increased connectivity in preclinical Alzheimer's disease. Alzheimers Dement (Amst) 10:471-479
Holingue, Calliope; Wennberg, Alexandra; Berger, Slava et al. (2018) Disturbed sleep and diabetes: A potential nexus of dementia risk. Metabolism 84:85-93
Alosco, Michael L; Sugarman, Michael A; Besser, Lilah M et al. (2018) A Clinicopathological Investigation of White Matter Hyperintensities and Alzheimer's Disease Neuropathology. J Alzheimers Dis 63:1347-1360
van Bergen, Jiri M G; Li, Xu; Quevenco, Frances C et al. (2018) Low cortical iron and high entorhinal cortex volume promote cognitive functioning in the oldest-old. Neurobiol Aging 64:68-75
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Kim, Sangjune; Yun, Seung Pil; Lee, Saebom et al. (2018) GBA1 deficiency negatively affects physiological ?-synuclein tetramers and related multimers. Proc Natl Acad Sci U S A 115:798-803
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Burke, Shanna L; Maramaldi, Peter; Cadet, Tamara et al. (2018) Decreasing hazards of Alzheimer's disease with the use of antidepressants: mitigating the risk of depression and apolipoprotein E. Int J Geriatr Psychiatry 33:200-211
Hohman, Timothy J; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau. JAMA Neurol 75:989-998

Showing the most recent 10 out of 830 publications